Caxton Associates (New York)’s CareTrust REIT CTRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-44,491
Closed -$859K – 589
2022
Q1
$859K Sell
44,491
-15,555
-26% -$307K 0.07% 135
2021
Q4
$1.37M Buy
60,046
+14,165
+31% +$300K 0.14% 70
2021
Q3
$932K Buy
45,881
+13,651
+42% +$308K 0.1% 107
2021
Q2
$749K Sell
32,230
-7,520
-19% -$177K 0.08% 107
2021
Q1
$926K Buy
+39,750
New +$913K 0.08% 75
2019
Q3
– Sell
-12,315
Closed -$293K – 415
2019
Q2
$293K Sell
12,315
-702
-5% -$17K 0.04% 289
2019
Q1
$305K Buy
+13,017
New +$285K 0.04% 243

Other funds holding CTRE

Caxton Associates (New York)'s CTRE Position: Q2 2022 in Review

Caxton Associates (New York) sold out of CareTrust REIT (CTRE) in Q2 2022, closing a stake of 44,491 shares — an estimated $859K sold.

Caxton Associates (New York) first reported a position in CTRE in Q1 2019 and held it in 7 quarters. The position peaked at $1.37M in Q4 2021. 230 funds tracked by Wall St. Rank hold CTRE as of Q2 2022.

  • Caxton Associates (New York) reported no remaining CareTrust REIT position as of Q2 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 44,491 CareTrust REIT shares in Q2 2022, an estimated $859K.
  • Caxton Associates (New York) first reported a position in CareTrust REIT in Q1 2019 and held it in 7 quarters.
  • Caxton Associates (New York)'s CareTrust REIT position peaked at $1.37M in Q4 2021.
  • 230 funds tracked by Wall St. Rank held CareTrust REIT as of Q2 2022.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.